Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 6Recruiting 2

Sponsor Class

OTHER 8NIH 2

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Neoplasms 30Prostatic Neoplasms 22Neoplasm Metastasis 20Breast Neoplasms 17Lung Neoplasms 16Colorectal Neoplasms 15Leukemia, Myeloid, Acute 14Pancreatic Neoplasms 13Ovarian Neoplasms 12Urinary Bladder Neoplasms 11Lymphoma 11Hematologic Neoplasms 11Carcinoma, Non-Small-Cell Lung 10Stomach Neoplasms 9Myelodysplastic Syndromes 9Squamous Cell Carcinoma of Head and Neck 8Sarcoma, Kaposi 8Pheochromocytoma 8Multiple Myeloma 8Melanoma 8Lymphoma, Non-Hodgkin 8Leukemia, Lymphocytic, Chronic, B-Cell 8Endometrial Neoplasms 8Carcinoma, Renal Cell 8Burkitt Lymphoma 8Neuroendocrine Tumors 7Mouth Neoplasms 7Kidney Neoplasms 7Glioma 7Thyroid Neoplasms 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × NIH × Lymphangioleiomyomatosis × Clear all
NCT00001465 2026-05-22

Study of the Disease Process of Lymphangioleiomyomatosis

National Institutes of Health Clinical Center (CC)

Recruiting
2,000 enrolled

Lung Diseases, Pneumothorax, Tuberous Sclerosis, Lymphangioleiomyomatosis

NCT01799538 2026-05-01

Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis

National Institutes of Health Clinical Center (CC)

Phase 1/2 Recruiting
100 enrolled

Lymphangioleiomyomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡